Lipoic acid supplementation and endothelial function

British Journal of Pharmacology

Volumn 153, Issue 8, 2008, Pages 1587-1588

  Tardif, J C ^a   Rheaume E ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Akt phosphorylation; Antioxidants; Ceramide; Endothelial function; Glutathione; Lipoic acid; Nitric oxide; Phosphatase activity; Sphingomyelinase

Indexed keywords

CERAMIDE; GLUTATHIONE; NITRIC OXIDE SYNTHASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE B; SPHINGOMYELIN PHOSPHODIESTERASE; THIOCTIC ACID;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEART PROTECTION; METABOLIC REGULATION; NONHUMAN; NOTE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RAT; SECONDARY PREVENTION; SHORT COURSE THERAPY; VASCULAR RING;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; THIOCTIC ACID;

EID: 42149158811     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.74     Document Type: Note

References (12)

1. Bowry VW, Ingold KU, Stocker R (1992). Vitamin E in human low-density lipoprotein: when and how this antioxidant becomes a pro-oxidant. Biochem J 288: 341-344.
2. Keaney Jr JF, Gaziano JM, Xu A, Frei B, Curran-Celentano J, Shwaery GT et al. (1994). Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest 93: 844-851.
3. Kunsch C, Medford RM (1999). Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85: 753-766.
4. Moubayed SP, Heinonen T, Tardif JC (2007). Anti-inflammatory drugs and atherosclerosis. Curr Opin Lipidol 18: 638-644.
5. Ross R (1999). Atherosclerosis - an inflammatory disease. N Engl J Med 340: 115-126.
6. Smith AR, Visioli F, Frei B, Hagen TM (2008). Lipoic acid significantly restores, in rats, the age-related decline in vasomotion. Br J Pharmacol 153: 1615-1622 (this issue).
7. Tardif JC (2006). Antioxidants: the good, the bad and the ugly. Can J Cardiol 22 (Suppl B): 61B-65B.
8. Tardif JC, Côté G, Lespérance J, Bourassa M, Lambert J, Doucet S et al. (1997). Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 337: 365-372.
9. Tardif JC, Gregoire J, Schwartz L, Title L, Laramée L, Reeves F, et al., Canadian Antioxidant Restenosis Trial (CART-1) Investigators (2003). Effects of AGI-1067 and probucol after percutaneous coronary interventions. Circulation 107: 552-558.
10. Zhang WJ, Bird KE, McMillen TS, LeBoeuf RC, Hagen TM, Frei B (2008). Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice. Circulation 117: 421-428.
11. Zhang WJ, Frei B (2001). Alpha-lipoic acid inhibits TNF-induced and NF-kB activation and adhesion molecule expression in human aortic endothelial cells. FASEB J 15: 2423-2432.
12. Zhang WJ, Wei H, Hagen T, Frei B (2007). Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc Natl Acad Sci USA 144: 4077-4082.